ANTISENSE MODULATION OF CD81 EXPRESSION

Details for Australian Patent Application No. 2002357101 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors GRAHAM, Mark, J.; DOBIE, Kenneth, W.

Pub. Number AU-A-2002357101

PCT Number PCT/US02/39182

PCT Pub. Number WO2003/053342

Priority 10/006,430 10.12.01 US

Filing date 9 December 2002

Wipo publication date 9 July 2003

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 10/006,430 10.12.01 US

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2002357101

26 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357102-ANTISENSE MODULATION OF CD36L1 EXPRESSION

2002357100-APPARATUS AND METHOD FOR IMPROVED CRYSTAL TIME REFERENCE